Innovation and evolution in Life Sciences
From molecule to medical breakthroughs: data powering insights to redefine care pathways
Science and technology are coming together to drive new levels of speed and agility across the sector. From bio-engineering breakthroughs to advances in computing, data analytics, machine learning and artificial intelligence, this new wave of innovation is combining to drive the development of new and improved treatment options, and to accelerate their delivery to the frontline. Focusing on the journey from drug discovery to clinical trials, we uncover the latest technologies and approaches, and analyze their transformational impact.
Share This:
The science of technology:
Personal perspectives from sector experts
In today’s hyperconnected Life Sciences ecosystem, innovation increasingly demands collaboration. Here, scientists and researchers from across the Life Sciences sector offer their personal reflections of a sector in change
Redefining discovery, accelerating breakthroughs
Dr. Gemma Holliday, Lead Cheminformatician at Medicines Discovery Catapult, looks at the complex world of drug discovery and shares her observations on how data is helping to unlock and accelerate exciting new treatments.
Driving insights and innovation in Life Sciences R&D
Dr. Katharina Lauer, Scientific Lead of BY-COVID at ELIXIR, shares her views on how the pandemic has helped shape the assimilation of scientific knowledge, and the role of bioinformatics in leveraging insight to drive innovation.
Biobanks: a pillar of precision medicine
Dr. Neeta Bhatia, Global Portfolio Lead (Precision Medicine) at Atos Digital Health Solutions looks at the evolution of disease- and population-based biobanks and the role they play in accelerating the move to precision medicine.
Sounding out wearables for Health Diagnostics
Professor Cecilia Mascolo, who heads up the Mobile Systems Research Laboratory at Cambridge University, UK shares insights on how disruptive innovations and digital apps are helping to change the future of population healthcare.
“The collaborative sharing of open data sets that occurred in response to the COVID-19 pandemic demonstrates how drug discovery could be catalyzed to deliver huge benefits for public health.”
Dr. Gemma Holliday, Lead Cheminformatian at Medicines Discovery Catapult,
More insights
Blog
Faster disease detection with Computer Vision
Dr Natalia Jimenez shares her views on how Computer vision can help to detect conditions before they become illnesses.
Blog
Transforming the drug discovery process with digital
How digital could help pharma reduce dependencies on external factors for clinical trials through remote data capture.
Video
Virtual Humans
Peter Coveney discusses the future of medicine through the illustration of virtual humans and how technology is key in accelerating and supporting more informed research.
Podcast
Drug Discovery and Data Podcast
Listen to our latest podcast as we speak to two professionals, Gemma Holliday and Gayle Marshall, to learn more about the different stages of drug discovery and the critical role data plays in each stage. Gemma is the Lead of Cheminformatics at Medicine Discovery Catapult, and Gayle is her colleague, Head of the Biomarkers department. Our speakers also touch upon the cutting-edge technologies utilized in drug discovery and shed light on what digital technology companies can do to facilitate these complex processes.